亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢遠城科技發展有限公司銷售八部  

肉桂酸、肉桂醛、肉桂醇、及公司經營的生物化工、醫藥中間體等產品

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:劉
  • 電話:02788320827
  • 郵件:yucheng011@yuanchengdope.com
  • 傳真:02788048077
  • QQ:172616357
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 雙氯芬酸鈉
雙氯芬酸鈉
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2011-04-16 11:44
 
詳細信息
雙氯芬酸鈉
英文名稱: diclofenac sodium
中文別名: 雙氯滅痛; 雙氯滅痛鈉; 服他靈; 雙氯胺苯乙酸鈉;  
化學名稱: 2-[(2,6-二氯苯基)氨基]-苯乙酸鈉 
CAS  號: 15307-79-6  
分 子 式: C14H10Cl2NNaO2 
分 子 量: 318.13  
質量標準:USP/BP
性狀:白色或類白色結晶性粉末,易溶于甲醇、乙醇,
稍難溶于水。
用   途: 解熱鎮痛,適用于類風濕性關節炎、骨關節病、
手術后止痛及各種原因引起的發熱。 
包裝規格: 25公斤/紙桶
diclofenac sodium
Diclofenac sodium
Chinese alias: diclofenac sodium; diclofenac sodium; 
clothes his soul; double chloramine sodium phenylacetate;
Chemical Name: 2 - [(2,6 - dichlorophenyl) amino] - acetic acid sodium
CAS Number: 15307-79-6
Packing: 25kg cardboard drum
Molecular formula: C14H10Cl2NNaO2
Molecular Weight: 318.13
Quality Standard: USP / BP
Appearance: white or almost white crystalline powder, 
soluble in methanol, ethanol, slightly soluble in water is difficult.
Uses: anti-inflammatory for rheumatoid arthritis, osteoarthritis, 
postoperative pain and fever caused by a variety of reasons.
Packing: 25 kg / drum 

©2025 武漢遠城科技發展有限公司銷售八部 版權所有   技術支持:化工網   訪問量:27684  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |